Faeth Therapeutics, Inc. (FTH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$35.29

From 52W high−13.86%

Volume2.17M

Market cap$891.49M

P/E (TTM)—

P/S (TTM)−183.8x

Div yield—

Key dataSep 18, 2026

Open

$35.29

From 52W high

−13.86%

Volume

2.17M

Market cap

$891.49M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

P/E (TTM)

—

RSI (14)

50.8

MomentumView details →

1D Return

−1.79%

YTD Return

+226.34%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−3.6x

EV/Sales

−145.5x

P/S (TTM)

−183.8x

P/B (TTM)

5.2x

ProfitabilityView details →

Gross Margin

2740.82%

Net Margin

4030.69%

EBITDA Margin

4027.97%

ROE (TTM)

−113.05%

ROA (TTM)

−103.29%

Asset Turnover

−0.02x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+30.36%

EBITDA YoY

—

MomentumView details →

1D Return

−1.79%

YTD Return

+226.34%

1Y Return

+286.89%

RSI (14)

50.8

vs 50D SMA

+9.20%

vs 200D SMA

+51.64%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

19.69x

Quick Ratio

19.69x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.84

EPS Surprise

−7.58%

Beats (12Q)

0/12

Next Q EPS Est

−$0.78

Avg Surprise (4Q)

−7.58%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

−4.85M

Net Income (TTM)

−195.53M

Op. CF (TTM)

−33.86M

Next earningsNov 13, 2026 →

Latest newsMore news →

No recent news for FTH.

Similar companies

Inventiva S.A.IVA Immix Biopharma, Inc.IMMX Avalo Therapeutics, Inc.AVTX Theravance Biopharma, Inc.TBPH Ardelyx, Inc.ARDX Cybin Inc. Common StockHELP Find similar companies →

Latest newsMore news →

No recent news for FTH.